MTOR and kidney neoplasm: In conclusion, herein, we present a distinct renal tumor characterized by high-grade eosinophilic cells, cathepsin-K (clone 3F9) immunohistochemical expression, and harboring mTOR gene mutation demonstrating a malignant potential and showing responsiveness to an mTOR inhibitor-containing combination.